About
Sascha Alilovic spent around 20 years in transactional roles such as M&A, IPOs, and other capital markets transactions, founded corporate finance boutiques, and held leadership positions at global companies before joining SHS in 2018. He also gained roughly a decade of operational experience at a biotech company. At SHS he is responsible for fundraising and focuses on the end stage of the investment lifecycle, including matching portfolio companies with strategic or financial buyers. He serves on several supervisory boards of medtech and life-science supplier companies.
Invests in
BiotechMedical Devices
Experience
- SHS Gesellschaft für BeteiligungsmanagementManaging Partnercurrent2020 — presentTübingen, Baden-Württemberg
- SHS Gesellschaft für BeteiligungsmanagementPartner2018 — 2020Tübingen Area, Germany
- SHS Gesellschaft für BeteiligungsmanagementSenior Advisor2017 — 2018Tübingen Area, Germany
- MESIBoard Membercurrent2023 — presentLjubljana Metropolitan Area
- Level 20 DACHMentorcurrent2020 — present
- TyromotionShareholder Representativecurrent2020 — presentGraz, Austria
- PathoQuestBoard Member2021 — 2026Greater Paris Metropolitan Region
- Neuro Event Labs OyBoard Member2020 — 2024Tampere Metropolitan Area
- Salvia BioElectronicsBoard Member2020 — 2021Eindhoven, North Brabant, Netherlands
- GNA Biosolutions GmbHShareholder Representative2020 — 2021Munich Area, Germany
- MorphoSys AGHead of Corporate Finance & Corporate Development2007 — 2018
- SiemensHead of Deal Team2006 — 2007
- SiemensSenior Consultant M&A2003 — 2006
- Clairfield InternationalDirector, Co-Founder2000 — 2003Frankfurt Am Main Area, Germany
- Value Management & Research AGAnalyst1999 — 2000
Education
- EBS Universität für Wirtschaft und RechtDiplom-Kaufmann, Finance1993 — 1998
- James Madison UniversityB.Sc., Computer Science1995
- Hilda GymnasiumAbitur, History1985 — 1993
Skills & more
Venture Capital31Mergers15Corporate Finance42Corporate Development45Due Diligence21Financial Modeling7International Business1Mergers & Acquisitions33M&A experience5Private Equity4Start-ups7Acquisition Integration5
+12 more
Investment BankingInvestor RelationsExecutive ManagementFinanceTechnology TransferRestructuringBusiness PlanningCommercializationStrategyBusiness StrategyManagement ConsultingEmerging MarketsFrom Sascha's professional profile.
Same school
Also attended EBS Universität für Wirtschaft und Recht58
Gülsah WilkeInvestor at DN CapitalJohn GregerCPO & Portfolio Partner at Burda Principal InvestmentsYi Min LohInvestment Associate at Burda Principal InvestmentsRouven DresselhausInvestor at Cavalry VenturesChristian WenigerVenture Partner at Storm VenturesAntonia Rojas EingFounder & Managing Partner at ATTOM CAPITAL
+ 52 more
Also attended James Madison University37
Margot AsmuthExecutive Assistant at RevolutionTom MartinVice President of Finance & Accounting at RevolutionTige SavageCo-founder at RevolutionKevin GasquePartner & Chief Operating Officer at GreycroftWill CoffieldCo-founder and General Partner at Riot VenturesRick KushelManaging Partner at FINTOP Capital
+ 31 more
Shared employers
Also worked at SHS Gesellschaft für Beteiligungsmanagement16
Markus EnzelbergerPartner at Versant VenturesHubertus LeonhardtSenior Partner at SHS CapitalCornelius MaasPartner at SHS CapitalDavid WehnerSenior Investment Manager at SHS CapitalLukas MaucherDeputy Managing Partner, CFO at SHS CapitalGuillaume BalzSenior Investment Manager at SHS Capital
+ 10 more
Also worked at Level 20 DACH1
Also worked at PathoQuest1
Also worked at Neuro Event Labs Oy1
Colleagues at SHS Capital
André Zimmermann
Partner at SHS Capital
Cornelia Gänsicke
Head of Controlling and authorized signatory at SHS Capital
Cornelius Maas
Partner at SHS Capital
David Wehner
Senior Investment Manager at SHS Capital
Dr. André Zimmermann
Partner at SHS Capital
Dr. Cornelius Maas
Partner at SHS Capital
Dr. Michael Lichtenberg
Healthcare Expert at SHS Capital
Elisaveta Slobodyanik
Accounting and Controlling at SHS Capital